IFL (chemotherapy)

From Wikipedia, the free encyclopedia
Jump to: navigation, search

IFL is a chemotherapy regimen for treatment of certain cancers, consisting of concurrent treatment with irinotecan, leucovorin (folinic acid), and fluorouracil.[1]

It is similar to the FOLFIRI regimen and uses the same drugs. However, the fluorouracil component is given as a bolus injection rather than as an infusion over 48 hours.[1]

See also[edit]

References[edit]